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Efflux of cytosolic Ca2mediated by plasmamembraneCa2-
ATPases (PMCA) plays a key role in fine tuning the magnitude
and duration of Ca2 signaling following activation of G-pro-
tein-coupled receptors. However, the molecular mechanisms
that underpin the trafficking of PMCA to themembrane during
Ca2 signaling remain largely unexplored in native cell models.
One potential mechanism for the recruitment of proteins to the
plasma membrane involves PDZ interactions. In this context,
we investigated the role of PMCA interactions with theNa/H
exchanger regulatory factor 2 (NHERF-2) during muscarinic-
inducedCa2mobilization in theHT-29 epithelial cell line.GST
pull-downs in HT-29 cell lysates showed that the PDZ2module
of NHERF-2 bound to the PDZ bindingmotif on the C terminus
of PMCA. Co-immunoprecipitations confirmed that PMCA1b
and NHERF-2 associated under normal conditions in HT-29
cells. Cell surface biotinylations revealed significant increases in
membrane-associated NHERF-2 and PMCAwithin 60 s follow-
ing muscarinic activation, accompanied by increased associa-
tion of the two proteins as seen by confocal microscopy. The
recruitment of NHERF-2 to the membrane preceded that of
PMCA, suggesting that NHERF-2 was involved in nucleating an
efflux complex at the membrane. The muscarinic-mediated
translocation of PMCA was abolished when NHERF-2 was
silenced, and the rate of relative Ca2 efflux was also reduced.
These experiments also uncovered a NHERF-2-independent
PMCA retrieval mechanism. Our findings describe rapid ago-
nist-induced translocation of PMCA in a native cell model and
suggest that NHERF-2 plays a key role in scaffolding and main-
taining PMCA at the cell membrane.
Achange in the concentration of cytosolic Ca2 ([Ca2]i) is a
key initiator of a multitude of cellular responses. Low resting
[Ca2]i is maintained by the sequestration of Ca2 into intra-
cellular stores or the extrusion of Ca2 across the plasmamem-
brane by transporters such as the ubiquitous plasmamembrane
Ca2-ATPase (PMCA)3 (1). Many G-protein-coupled recep-
tors (GPCRs) (such as purinergic and muscarinic receptors)
signal via transient increases in [Ca2]i to effect physiological
responses (2). The increase in [Ca2]i is biphasic, with an initial
mobilization of Ca2 from intracellular stores which in turn
triggers Ca2 influx via ion channels in the plasma membrane.
Following termination of receptor signaling, [Ca2]i returns
rapidly to resting levels due to refilling of the sarcoplasmic/
endoplasmic reticulum as well as Ca2 efflux mediated by
PMCA and/or Na-Ca2 exchange (3). Thus the magnitude
and duration of the increase in [Ca2]i during the activation of
a GPCR signaling cascade reflects a dynamic equilibrium
between influx, reuptake, and efflux.
Since the discovery of PMCA in the erythrocyte membrane
in the mid-1960s (4), this ubiquitous enzyme has been well-
defined as a primary mechanism for Ca2 efflux from eukary-
otic cells to maintain low resting Ca2 levels (5). PMCA is
encoded by four separate genes that give rise to four distinct
variants; PMCA1, -2, -3, and -4 (6). PMCA1 and -4 are thought
to be ubiquitous, while the expression of PMCA2 and -3 is
much more restricted predominantly in the brain and striated
muscle (7, 8). Alternate splicing of the original transcripts indi-
cates that there are numerous PMCA variants in the mamma-
lian proteome (9). The diversity of splice variants of PMCA is
thought to allow for the complex and dynamic, spatio-temporal
regulation of cell-specific Ca2 handling (6).
The level of complexity of Ca2 signaling may be increased
by spatially constraining various regulatory components asso-
ciated with the movement of Ca2. Such supramolecular sig-
naling platforms are already described for store-operated Ca2
channels as well as their upstream, downstream, and regulatory
components (10), and PMCAs are also reported to be part of
such store-operated signaling complexes (11). PMCAs are
known to interact with a number of cytosolic accessory and
scaffold proteins that candirect the formation ofCa2 signaling
microdomains. These scaffolds include PSD-95/Dlg/Zo-1
(PDZ) proteins that are now recognized as playing key roles in
aggregating receptors, ion channels, and transporters into
functionally specific complexes in membrane microdomains
(12–14). Due to alternate splicing of the mRNA transcripts at
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the C-terminal tail splice site C, there are 2main variants of the
PMCA isoforms denoted PMCAa andPMCAb. Importantly, all
PMCAb splice variants have a PDZ consensus binding motif at
their C terminus that has been shown to bind a wide variety of
PDZ proteins (15–19). Some of these interactions have been
shown to be physiologically relevant; for example, PDZ-medi-
ated interactions between PMCA4b and nitric-oxide synthase I
(NOS1) are essential for the regulation NO synthesis in the
heart (20, 21).
One family of PDZ proteins are the Na/H exchanger reg-
ulatory factors, denoted NHERF-1 to -4 (22, 23). NHERF-1 was
the first PDZ scaffold identified for an epithelial transporter. It
was shown to direct the formation of a multi-protein complex
thatmediated cAMP-regulated protein kinase (PKA) phospho-
rylation and inhibition of the Na/H exchanger 3 (NHE3)
(24–27). NHERF-1 and -2 contain two PDZ modules (PDZ1
and PDZ2) that bind the PDZ binding motifs in the C terminus
of target ion channels, receptors, and transporters (23).
NHERF-1 and -2 also contain a C-terminal ezrin-radixin-moe-
sin (ERM) binding domain that interacts with ERM proteins to
link to the actin cytoskeleton. NHERF-1 and -2 can also nucle-
ate the formation of macromolecular complexes by physically
linking plasma membrane proteins to the cytoskeleton and
recruiting signalingmolecules such as PKA (26), protein kinase
C (PKC) (28), and phospholipase C (PLC) (29) to the com-
plex. Examples include the NHE3-NHERF-1-ezrin and NaPi-
IIa-NHERF-1-ezrin complexes anchored to the actin cytoskel-
eton in the brush border membrane of renal proximal tubule
cells (30) and the CFTR-NHERF-1/2-ezrin complex found in
airway epithelial cells (31, 32). NHERF-2 has been reported to
interact with PMCA2b when it was transiently transfected in
(Madine Darby Canine Kidney)MDCK cells (18). However, the
physiological relevance of the interaction between PMCAs and
NHERF-2, particularly in the context of endogenous GPCR-
mediated increases in [Ca2]i remain unexplored. Many of the
intracellular kinases that have been shown to bind NHERF-2
such as PKC and PKA are also regulators of PMCA (33). Coor-
dinated signaling via NHERF-2 and modulation of PMCA-me-
diated efflux introduces a level of complexity that may account
for the differences observed in the morphology of Ca2
responses following GPCR activation (34).
The human colonic epithelial cell line (HT-29) is an accepted
model for studying Ca2 signaling in epithelial cells and
expresses only the M3 isoform of the muscarinic receptor (35).
Muscarinic activation of HT-29 cells increases [Ca2]i follow-
ing activation of PLC by the -subunits and release of Ca2
stores and subsequentCa2 influx (34, 36). Although themech-
anisms of muscarinic receptor-mediated Ca2mobilization in
these cells have beenwell established (34, 36, 37), little is known
about the role of PMCA-mediated Ca2 efflux in this pathway.
The current study was undertaken to determine the functional
relevance of the interactions between NHERF-2 and PMCA in
the context of muscarinic receptor-mediated Ca2 signaling in
HT-29 cells.
EXPERIMENTAL PROCEDURES
Cell Culture, Transfection, and siRNA—The human colorec-
tal adenocarcinoma cell line HT-29 (ATCC) was maintained in
standard RPMI 1640 medium (Invitrogen), 10% turbo calf
serum (Invitrogen) and 1% (v/v) penicillin/streptomycin
(Invitrogen) at 37 °C, 5% CO2. Cells used in this study were
between passages 20–40. Human embryonic kidney HEK293
cells (ATCC) were maintained in Dulbecco’s modified Eagle’s
medium (Invitrogen), 10% turbo calf serum (Invitrogen), and
1% (v/v) penicillin/streptomycin (Invitrogen) at 37 °C, 5% CO2.
Transfections were performed using Lipofectamine 2000
(Invitrogen) according to the manufacturer’s instructions. For
the experiments to silence NHERF-2, HT-29 cells were trans-
fected with plasmids encoding siRNA directed against two dif-
ferent regions of NHERF-2 (Shag-274 and Shag-361) or control
(Shag-FF). These plasmids have been shownpreviously to effec-
tively suppress the endogenous levels of NHERF-2 (38, 39). All
experiments were performed 48-h post-transfection.
Antibodies—Monoclonal antibodies 5F10 and JA9 (Affinity
Bioreagents), have been previously characterized (40, 41). 5F10
is a pan-PMCA antibody that recognizes a highly conserved
epitope near the PMCA active site common to all PMCA iso-
forms, while JA9 is specific for PMCA4. Generation of the spe-
cific antibodies against NHERF-1 and -2 was previously
described (27). ThemonoclonalGFP antibodywas fromMolec-
ular Probes (Invitrogen).
RNA Isolation and PCR—Total RNA was extracted from
HT-29 cells using the TRIzol reagent following the manufac-
turer’s instructions (Invitrogen). RNA (100 ng) was reverse-
transcribed using the One-Step RT-PCR kit (Qiagen, Hilden,
Germany) with primers based on mouse NHERF-1 and -2 (39).
-Actin was used as a housekeeping gene using commercially
available primers (Promega). Samples without the reverse tran-
scriptasewere also run in parallel as a control. The PCRwas run
for 20 cycles at 94, 55, and 72 °C, 1 min each. RT-PCR products
were electrophoresed on a 2% agarose gel and visualized with
ethidium bromide.
Cell Surface Biotinylation and Western Blotting—Flasks (75
cm2) of confluent HT-29 cells were washed three times in PBS
at room temperature. Cells were according to experimental
conditions first preincubated with 50 M BAPTA-AM (1,2-
bis(o-aminophenoxy) ethane-N,N,N,N-tetraacetic acid-ace-
toxymethylester, Invitrogen) for 30min, then exposed to either
acetylcholine (ACh, 10 M) or cyclopiazonic acid (CPA, 5 M).
At the given time points, the flasks were immediately placed on
ice and washed three times in ice-cold PBS. Cells were then
exposed to Sulfo-NHS-biotin (Pierce Biotechnology Inc.) (1.22
g/ml) for 45 min at 4 °C. This was followed by a wash of 100
M glycine in PBS at 4 °C for 5 min to quench excess biotin,
followed by three more washes of cold PBS. Cells were solubi-
lized in 150mMNaCl, 20 mMHEPES, 1 mM EDTA, 1%Nonidet
P-40 (Roche Applied Science), complete protease inhibitor
(RocheApplied Science) for 30min at 4 °C. Insoluble cell debris
was removed by centrifugation. Protein quantification was
done on the supernatants then equal amounts of lysate were
mixed with immunopure streptavidin (Pierce Biotechnology
Inc.) for 30 min with end-to-end rotation at 4 °C. Protein was
eluted off the beads using 6 SDS loading dye and run on 10%
SDS-PAGE gel. Gels were transferred to nitrocellulose mem-
brane and stained with Ponceau-S to visually confirm equal
loading of membrane fraction. Blots were then blocked for 1 h
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in 5% skim milk powder in Tris-NaCl-Tween buffer (TBS-T).
Primary antibodywas incubated overnight at 4 °C (5F10 1:2000,
JA9 1:1000, and NHERF-1 -2, 1:5000) in TBS-T. Blots were
washed four times with TBS-T, incubated for 1 h with horse-
radish peroxidase-conjugated secondary antibody (Pierce Bio-
technology Inc.) and washed again. Immunoreactive proteins
were detected by enhanced chemiluminescence using the
SuperSignal kit (Pierce Biotechnology Inc).
Expression and Purification of Fusion Proteins—Full-length
NHERF-1, NHERF-2, and individual domains of NHERF-2
(PDZ1, PDZ2, and COOH) cloned into pGEX4T-1 have been
described previously (42). Glutathione S-transferase (GST)
fusion proteins were expressed in the Escherichia coli strain
BL21 (Stratagene). Optimal expression of fusion proteins was
achieved by adding a final concentration of 2 mM isopropyl-ß-
D-thiogalactopyranoside to the bacterial culture, with over-
night incubation at 22 °C. The bacteria were harvested by cen-
trifugation and resuspended in PBS. After sonication, GST
fusion proteins were purified using glutathione-Sepharose 4B
beads (Amersham Biosciences) following the manufacturer’s
instructions.
GST Pull-downs—HT-29 cells were solubilized in lysis buffer
(150 mM NaCl, 50 mM Tris-Cl, 0.5% Nonidet P-40, protease
inhibitors) for 1 h at 4 °C, lysates were centrifuged at 4 °C, and
the supernatant collected. Lysates for the pull-down experi-
ment investigating the Ca2 dependence of PMCA-NHERF-2
interactions had an additional 100 M BAPTA free acid. GST
fusion proteins (10 g) were bound to Sepharose in GST bind-
ing buffer (lysis buffer, 5mMdithiothreitol) for 3 h at 4 °C; the
beads were washed three times in wash buffer (GST binding
buffer, 0.0075% SDS) and once in lysis buffer. The cell lysate
(5–10mg)was then incubatedwithGST fusion protein beads in
lysis buffer at 4 °C overnight with gentle rotation. Bound pro-
teins were washed three times with lysis buffer (no protease
inhibitor) and resuspended in SDS sample buffer. The samples
were resolved by SDS-polyacrylamide gel electrophoresis,
Western-blotted and probed with the appropriate antibodies.
Co-immunoprecipitation—HT-29 cell lysates were prepared
following activation with 10MACh 60 s. The supernatant was
collected and incubated with 50l of protein A-agarose (Roche
Applied Science) for 3 h at 4 °C. Cleared cell lysate (3 mg) was
incubated with NHERF-1 and NHERF-2 antibodies overnight
at 4 °C. Protein complexes were recovered using protein A-aga-
rose beads for 4 h, and subsequent complexes recovered in SDS
loading buffer. Samples were run on an 10% SDS-PAGE gel and
Western blots performed using appropriate antibodies.
In Vitro Binding Assay—The 130-amino acid C-terminal tail
of PMCA1b and the tail minus the PDZ binding motif were
cloned into pGFP-C1N (Clontech), using the BamH1/Sal1 site
andwere PCR-amplified using the following primers: PMCA1b
fwd-gcgtcgacgagattgatcacgctgaaacc, PMCA1b: rev-cgcggatcct-
tcagagtgatgtttcc, PMCA1b-PDZ: rev-ctggatccctcaaactatg-
tagtggg. PCR amplicons were ligated into pGFP-C1N to make
the constructs GFP-PMCA1b-CT and GFP-PMCA1b-PDZ.
Constructs were transfected into HEK cells and left for 48 h to
allow optimal transgene expression. Cells were solubilized in
GST lysis buffer (as described above). Using the sameGSTpull-
down protocol as previously described, GST-NHERF-2 bound
to Sepharose beads were incubated with the cell lysates pro-
duced. Complexes were recovered, run on a Western blot, and
probed with the anti-GFP antibody (Invitrogen).
Measurement of Cytosolic [Ca2]—[Ca2]i measurements
were performed using the fluorescent ratiometric Ca2 dye
Fura-2 (Fura-2 AM, Invitrogen). The efflux of free [Ca2]i was
determined using a fluorescence microplate reader to monitor
the rate of decline in [Ca2]i after the generation of ACh-
evoked Ca2 transients. Cells were seeded in tissue culture-
treated black 96-well plates (PerkinElmer Life and Analytical
Sciences, VIC, Australia). Before experimentation, cells were
washed twice in HEPES buffered salt solution (HBSS, 137 mM
NaCl, 5mMKCl, 2mMCaCl2, 1mMMgCl2, 10mMD-glucose, 10
mMHEPES; pH adjusted to 7.4 with NaOH), and loaded with 5
M Fura-2 in the same buffer for 1 h at 37 °C with gentle shak-
ing. After loading, cells were washed three times in HBSS to
remove excess dye. All experiments were performed in a BMG
Fluostar Optima (BMG Lab Technologies, Offenburg, Ger-
many) using 340 nm, 380 nm excitation, and 520 nm emission
filters (BMG Lab Technologies). An automated injection of
agonist was made at 20 s to give final well concentrations of
ACh(10 M) and CPA (5 M). The ratio of the emission at 520
nm relative following 348/380 nm excitation represent the rel-
ative changes in [Ca2]i.
Relative PMCA-mediated Ca2 efflux was assessed based on
previously described methods (43). For Ca2 efflux measure-
ments the HBSS buffer was removed, and cells were washed
once with loading buffer and then twice with Na/Ca2-free
HBSS in which Na was replaced by N-methyl-D-glucamine
andwhich contained 100MBAPTA-tetra-K salt (cell imper-
meant BAPTA, Sigma Aldrich). The solution in which the ago-
nist was injected also contained 5 M CPA to prevent Ca2
reuptake by the sarco/endoplasmic reticulum Ca2 ATPase
(SERCA). This Na/Ca2-free HBSS buffer also prevents any
possible contribution of Na/Ca2 exchange. The rate of
decline in [Ca2]i measured under these conditions was pre-
dominately a measure of PMCA-mediated efflux of cytosolic
Ca2. In some experiments in which NHERF-2 was silenced,
Ca2 store release was determined without the inclusion of
CPA in the agonist solution. The relative rate of recovery from
the peak Ca2 transient was measured by fitting the declining
phase of the [Ca2]i transient with a monoexponential curve
over 30 s, commencing 20 s after the peak.
Immunohistochemistry and Confocal Microscopy—HT-29
cells were grown on 12-mm glass coverslips. Cells were incu-
bated in HBSS  10 M ACh for 60 s, then fixed in 4%
paraformaldehyde for 15 min. Cells were washed four times in
PBS and blocked for 1 h at room temperature in blocking buffer
(3% normal horse serum, 0.5% bovine serum albumin, and
0.05% Triton X-100). Cells were then washed two more times
with PBS, then primary antibodies (pan-PMCA 1:1000 and
NHERF-2 1:500) were applied in blocking buffer for 1 h at room
temperature. Cells were washed four times in PBS, and second-
ary antibody was applied (Alexa-Fluor 488 and 546, Invitrogen,
1:500) for 30 min. Cells were washed again four times in PBS
and mounted onto glass slides using Prolong-Gold mounting
medium (Invitrogen) according to the manufacturer’s instruc-
tions. Cells were visualized using a Zeiss LSM 510 meta confo-
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cal microscope using a 488-nm argon and 543-nm HeNe laser
(Carl Zeiss, Oberkochen, Germany). Images were taken using
Plan-Apochromat 63 and 100, 1.4 oil immersion objectives.
All images were captured and analyzed using Zeiss LSM image
viewer.
Statistical Analysis—Statistical significance was assessed
usingANOVAwith aTukey-Neumanpost-test. Datawere con-
sidered statistically significant when p 0.05. Unless otherwise
specified, results are presented as mean  S.E. Data from
microplate assays are representative of 3–4 independent assays
where each group was measured from 6–8 wells.
RESULTS
NHERF/PMCA Interactions in HT-29 Cells—We have previ-
ously reported that HT-29 cells express only PMCA1 and
PMCA4 isoforms (44). RT-PCR confirmed that theHT-29 cells
used in this study expressed the mRNA for NHERF-1 and
NHERF-2 (Fig. 1A). Western blotting also confirmed that
HT-29 cells expressed readily detectable levels of both
NHERF-1 and NHERF-2 protein (Fig. 1, B and C). It has been
shown recently, using heterologous expression systems that the
CNS isoform PMCA2b interacts with NHERF-2 (18). Impor-
tantly, PMCA1b has a Class 1 PDZ binding motif identical to
that of PMCA2b (6). HT-29 cell lysates were incubated with
GST fusion proteins of either full-length NHERF-1 or
NHERF-2, the bound proteins were eluted, and then run on
Western blots and probed with the 5F10 antibody. We found
that NHERF-2 but not NHERF-1 interacted with PMCA (Fig.
2A). In parallel we performed these experiments using three
GST fusion proteins that encoded
the individual binding domains of
NHERF-2; PDZ1, PDZ2, and the
C-terminal ezrin binding domain.
These data revealed that PMCA in
HT-29 cells bound the PDZ2 mod-
ule of NHERF-2 (Fig. 2A). GST pull-
downs rely on an added excess of
fusion proteins and can therefore
unmask low affinity interactions. To
confirm that the interaction between
PMCAandNHERF-2occurred in the
presenceof endogenous levels of each
protein we also performed co-immu-
noprecipitation experiments. These
experiments were also performed in
the presence of ACh to determine
whether the PMCA/NHERF-2 inter-
action was altered during muscarinic
receptor activation. Cell lysates were
prepared from cells treated  ACh
for 60 s, the lysates then incubated
with anti-NHERF-1 or NHERF-2
antibodies, and the resultant com-
plexes resolved byWestern blotting.
Under these conditions, NHERF-2,
but not NHERF-1, interacted with
PMCA (Fig. 2B, panel i) and inter-
estingly the level of interaction was
not altered in the presence of ACh.
The above experiments used a
pan-PMCA antibody as PMCA1-
specific antibodies were not found
to be suitable for these experiments.
FIGURE 1. HT-29 cells express NHERF-1 and NHERF-2. A, RT-PCR showing
mRNA in HT-29 cells for both NHERF-1 (lane 3, 461 bp) and NHERF-2 (lane 4,
364 bp), no reverse-transcriptase control (lane 1) and -actin control (lane 2).
B, Western blot for NHERF-1 in HT-29 cells showing a single band at50 kDa.
C, Western blot for NHERF-2 in HT-29 cells showing a band at45 kDa. West-
ern blots are representative of at least three individual experiments.
FIGURE 2. PMCA1 binding to NHERF-2 in HT-29 cells is mediated by the C-terminal PDZ motif. A, GST
pull-downs using pan-PMCA antibody showing that PMCA interactedwith NHERF-2 but not NHERF-1 in HT-29
cells, and the interaction was mediated by the second PDZmodule (PDZ2) of NHERF-2. B, co-immunoprecipi-
tations investigating the interaction between NHERF1/2 and PMCA. Lane a, HT-29 cell lysate control; lanes b
and c, immunoprecipitation with anti-NHERF-1 antibody; lanes d and e, immunoprecipitation with anti-
NHERF-2 antibody. B, panel i, blot probed with pan-PMCA antibody. B, panel ii, blot probed with anti-PMCA4
antibody. NHERF-2 interacted with PMCA, and this interaction occurred in the presence and absence of ACh.
C, Western blot showing HEK293 cells transfected with GFP-tagged PMCA1b C terminus PDZ bindingmotif
expressed proteins of the predicted size (50 kDa). D, pull-downs using GFP constructs of the C terminus of
PMCA1b PDZbindingmotif togetherwith GST-NHERF-2. The interactionwith NHERF-2was abolishedwhen
the C-terminal ETSLmotif was deleted (GFP-PMCA1b-DPDZ). Western blots are representative of at least three
individual experiments.
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However, HT-29 cells express only PMCA1 and PMCA4;
therefore, we repeated the co-immunoprecipitations using a
specific PMCA4 antibody. In this case we were unable to
demonstrate any interaction between NHERF-2 and PMCA4
(Fig. 2B, panel ii). Thus we can conclude that in HT-29 cells,
PMCA1b is the only PMCA isoform interacting with
NHERF-2.
PDZ interactions are mediated typically by a 4-amino acid
C-terminal PDZ binding motif on the target protein. To con-
firm that the C-terminal PDZ motif was required for PMCA1b
binding toNHERF-2, wemade plasmidswithGFP tagged to the
C-terminal 130 amino acids of PMCA1b with or without the
last 4 C-terminal amino acids (ETSL); GFP-PMCA1b-CT and
GFP-PMCA1b-PDZ. These plasmids were transfected into
HEK293 cells, and the lysates run on Western blots with the
GFP antibody to confirm the proteins expressed correctly (Fig.
2C).We then usedGST-NHERF-2 to pull-down theGFP fusion
proteins from HEK293 cell lysates. As predicted, GFP-
PMCA1b-CT bound to NHERF-2 and this interaction was
abolished when the PDZ binding motif was deleted (GFP-
PMCA1b-PDZ) (Fig. 2D).
Agonist-induced Trafficking of PMCA and NHERF-2 to the
Plasma Membrane—For many membrane proteins only a
small fraction of the total cellular pool of the protein is
expressed at the plasma membrane, with the rest stored in
intracellular recycling pools from which they can be rapidly
recruited to or from the membrane (45, 46). For example, it
has been shown in the ileum that NHE3 exists in multiple
dynamic pools and activation with ACh causes a rapid trans-
location from the membrane to early endosomes (47). Sig-
nificant levels of PMCA are also found in the non-biotiny-
lated fraction (see Fig. 3A), so it can be predicted that similar
mechanisms exist for the trafficking of PMCA to the mem-
brane from these pools. We therefore hypothesized that (i)
muscarinic mobilization of Ca2 would result in the trans-
location of PMCA to the plasma membrane and (ii) that the
recruitment of PMCA to the membrane requires a macro-
molecular complex that may involve NHERF-2 as a molecu-
lar scaffold. Cell surface biotinylation was used to determine
changes in cell surface-associated PMCA and NHERF-2 dur-
ing a time course of muscarinic receptor activation. When
cells were exposed to ACh, the cell surface level of PMCA
increased by 55  11% above control levels (n  4; **, p 
0.01) within 60 s (Fig. 3, A–C). Interestingly, the levels of
PMCA returned to control levels within 120 s despite the
continued presence of the agonist. Importantly, we found
that the cell surface associated levels of NHERF-2 also
increased in response to ACh. The translocation of
NHERF-2 to the membrane preceded that of PMCA.
NHERF-2 levels increased significantly by 45  6% above
control levels (n  4; **, p  0.01) within 30 s of exposure to
ACh and reached a peak at 80 11% above control after 60 s
(n  4; ***, p  0.001) (Fig. 3, D–F). Similar to PMCA, the
surface levels of NHERF-2 also returned to resting levels by
120 s while ACh was still present. The blots were stripped
and re-probed for PMCA4. No significant changes were
observed in the levels of cell surface PMCA4 (data not
shown), indicating that PMCA1 was the isoform that trans-
located and interacted with NHERF-2.
Trafficking of PMCA in Response to Muscarinic Stimulation
Is Dependent on NHERF-2—The above data were consistent
with NHERF-2 playing a key role in scaffolding/nucleating
the assembly of a PMCA Ca2 efflux complex at the mem-
brane. We hypothesized that silencing NHERF-2 would
therefore prevent the translocation of PMCA to the mem-
brane. HT-29 cells were transfected with silencing con-
structs (Shag-274 and Shag-361) directed against two differ-
ent regions of NHERF-2 or empty vector control (Shag-FF)
(39). Both silencing constructs caused a significant decrease
in endogenous NHERF-2 protein to 57 5% and 54 6% for
Shag-274 and 361, respectively (n  4; **, p  0.01) com-
pared with the Shag-FF control (Fig. 4, A and B). Silencing of
NHERF-2 was specific as the levels of NHERF-1 were unal-
tered (n 4) (Fig. 4C). We then investigated the dynamics of
ACh-mediated PMCA translocation in HT-29 cells that
NHERF-2 had been silenced. When endogenous NHERF-2
was knocked down, the translocation of PMCA to the mem-
brane at the 60-s time point was effectively abolished (Fig. 4,
D and E). Furthermore at the later time points, the levels of
PMCA dropped significantly below control (unstimulated)
levels to 46 5% (Shag-274) and 53 7% (Shag-361) at 120 s
(n 3; ***, p 0.001) (Fig. 4, D and E). These data indicated
that NHERF-2 was responsive to muscarinic receptor acti-
vation and that the subsequent translocation of PMCA to the
membrane required NHERF-2. Importantly, the reduction
FIGURE 3. Changes in plasma membrane-associated PMCA and NHERF-2
followingmuscarinic activation.HT-29 cellswereexposed toACh (10M), and
cell surface biotinylation was used to determine surface levels of PMCA and
NHERF-2. A, representative Western blot of non-biotinylated PMCA fraction.
B, representativeWesternblot showingthe time-dependent increaseofPMCAat
the plasma membrane after muscarinic activation. C, ACh caused a transient
increase by 55 11% (n 4; **, p 0.01) in plasma membrane PMCA at 60 s.
D, representative Western blot of non-biotinylated NHERF-2 fraction. E, repre-
sentativeWestern blot showing the time-dependent increase of NHERF-2 at the
plasmamembraneaftermuscarinicactivation.F, AChcauseda transient increase
by456%(n4; **,p0.01)ofplasmamembrane-associatedNHERF-2within
30 s and reached a peak to 85 13%above control levels (n 4; ***, p 0.001)
after 60 s. Data are expressed asmean S.E.
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of PMCA below control levels suggested that a different
mechanism, that did not involve NHERF-2, was responsible
for the retrieval of membrane-associated PMCA.
Co-localization of PMCA and NHERF-2—If NHERF-2 and
PMCA functionally interact, they must also exhibit spatio-
temporal colocalization. We used confocal immunofluores-
cence microscopy to monitor changes in the subcellular dis-
tribution of PMCA and NHERF-2. In control HT-29 cells
(unstimulated), both PMCA and NHERF-2 were widely dis-
tributed throughout the cytosol, with some colocalization
observed (Fig. 5A, panels i–iii).
Z-scans revealed that the two pro-
teins were distributed largely at
the apical and lateral domains.
(Fig. 5B, panels i–iii). Merging of
both channels revealed that there
was significant co-localization of
the proteins even in unstimulated
cells, a finding that is consistent
with the co-immunoprecipitation
data. When the cells were exposed
to ACh for 60 s, there was a pro-
nounced increase in co-localiza-
tion (Fig. 6A, panels i–iii). This
was more apparent in the z-scan,
where a significant redistribution
of both PMCA and NHERF-2 into
large distinct large puncta was ob-
served, with a higher level of co-
localization of the two proteins
(Fig. 6B, panels i–iii).
Silencing NHERF-2 Attenuates
PMCA-mediated Ca2 Efflux dur-
ingMuscarinic Signaling—Our data
suggest a highly dynamic model
for PMCA translocation during
acute receptor activation. The
next question was whether the
NHERF-2-dependent trafficking
of PMCA was physiologically rele-
vant. We therefore measured
the parameters of Ca2 signaling
using Fura-2 in a microplate-
based assay to determine the ef-
fect of silencing NHERF-2 on
muscarinic-induced Ca2 han-
dling. HT-29 cells were transfected
with Shag-274, Shag-361, or Shag-
FF, then loaded with Fura-2, and
assays performed in a microplate
reader. We first isolated the Ca2
recovery component predominately
due to PMCA (43). Here we
observed a significant reduction in
the rate of PMCA-mediated Ca2
recovery of 33 3% (Shag-274) and
36 4% (Shag-361) compared with
the control Shag-FF (n  4;***, p 
0.001) (Fig. 7, A and B). There was no effect of silencing
NHERF-2 on the peak increase in [Ca2]i (Fig. 7C). The data are
consistent with reduced translocation of PMCA to the plasma
membrane when NHERF-2 is silenced and suggests that the
interaction between PMCA and NHERF-2 plays a role in
PMCA-mediated Ca2 efflux. Reduced rate of recovery was
also observed when SERCA was not inhibited (50  3% Shag-
274 and 53 3% Shag-361; n 4; ***, p 0.001) (Fig. 7, D and
E). In this case, the difference in recovery rate was also not
due to changes in the peak [Ca2]i level attained (Fig. 7F).
FIGURE 4. Silencing of NHERF-2 abolishes muscarinic-mediated translocation of PMCA. NHERF-2 was
silenced in HT-29 cells using siRNA plasmids Shag-FF (vector control) and Shag-274 or Shag-361, exposed
to ACh (10 M), and cell surface biotinylation was used to determine surface levels of PMCA and NHERF-2.
A, representative Western blot demonstrating silencing of NHERF-2. B, Shag-274 and Shag-361 reduced
endogenous NHERF-2 protein levels to 57  5% and 54  6% (n  3; **, p  0.01). C, representative
Western blot showing endogenous NHERF-1 was not altered. D, representative Western blot showing
changes in membrane-associated PMCA following muscarinic activation in HT-29 cells silenced for
NHERF-2. E, densitometry showing changes in membrane-associated PMCA during muscarinic stimula-
tion in NHERF-2 knock-down cells. The ACh-mediated insertion of PMCA at 60 s was abolished. Further-
more, during stimulation the levels of PMCA in silenced cells reduced at 120 s to 46 5% (Shag-274) and
53  7% (Shag-361) compared with control (n  3; ***, p  0.001). Data are expressed as mean  S.E.
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Finally, silencing of NHERF-2 had no significant effect on
the rate of Ca2 influx as measured by Mn2 quenching of
Fura-2 (data not shown).
Store Release of Ca2 Is a Trigger for PMCA and NHERF-2
Translocation—We then investigated whether Ca2 leak
from intracellular stores was sufficient to initiate transloca-
tion of PMCA and NHERF-2 in the absence of GPCR activa-
tion. Cells bathed in a Ca2-free extracellular solution were
exposed to the SERCA pump inhibitor CPA, and changes in
Fura-2 ratio were monitored. This resulted in a characteris-
tic release of Ca2 from the intracellular stores (Fig. 8A) with
the peak Ca2 occurring at50–60 s after CPA application.
We then performed cell surface biotinylation experiments to
determine the effects of CPA on the translocation of both
PMCA and NHERF-2 to the membrane. Store release of
Ca2with CPA resulted in a time dependent translocation of
PMCA to the plasma membrane that reached a maximum at
120 s to 61  12% above resting levels (n  3; **, p  0.01)
and then returned to baseline by 300 s (Fig. 8B). Similarly,
store release resulted in a time-dependent translocation of
NHERF-2 reaching a maximum at 120 s at 180  11% above
control levels (n  3; ***, p  0.001) that also returned to
resting levels within 300 s (Fig. 8C). The movement of both
proteins paralleled the increase in [Ca2]i, and interestingly,
the movement of NHERF-2 appeared to precede that of
PMCA, similar to the effect observed following muscarinic
activation. Thus the translocation of both NHERF-2 and
PMCA to the plasma membrane can be triggered by store
release of Ca2 independent of GPCR activation.
ACh-evoked Trafficking of PMCA and NHERF-2 Is Altered in
the Presence of BAPTA-AM—There are other potential sig-
nals, in addition to changes in [Ca2]i that could trigger the
movement of NHERF-2 and PMCA to the membrane. To
determine if an increase in [Ca2]i was the sole stimulus for
translocation during muscarinic activation, we used cell per-
meable BAPTA-AM to chelate intracellular Ca2. The con-
centration of BAPTA-AM was optimized to ensure inhibi-
tion of the ACh-induced [Ca2]i transient (data not shown).
Cells were exposed to ACh for 60 s and cell surface biotiny-
lations performed. In unstimulated cells, chelation of intra-
cellular free Ca2 resulted in a significant increase in the
levels of membrane-associated NHERF-2 to 54  5% above
control cells (n  3; **, p  0.01) (Fig. 9, A and B). In cells
treated with BAPTA-AM, exposure to ACh further
increased membrane-associated NHERF-2 by 130  16%
over the unstimulated BAPTA-AM-treated cells (n  3; ***,
p  0.001) (Fig. 9, A and B). This suggests that the musca-
rinic-mediated increase in membrane-associated NHERF-2
may involve a Ca2-independent pathway. In the case of
PMCA, in unstimulated cells, treatment with BAPTA-AM
resulted in a pronounced increase in cell surface PMCA to
89  5% over control levels (n  3; ***, p  0.001) (Fig. 9, C
and D). However, when BAPTA-AM-treated cells were
exposed to ACh, there was no increase in cell surface-asso-
ciated PMCA (Fig. 9, C and D). This then raised the question
as to the Ca2 dependence of the binding between PMCA to
NHERF-2. Pull-downs were performed in HT-29 cell lysates
in the presence of 100 M extracellular BAPTA. The inter-
action between GST-NHERF2 and PMCA was unaltered in
the absence of Ca2 (Fig. 9, E and F). Taken together, these
data suggest that although the association of NHERF-2 and
FIGURE 5. PMCA and NHERF-2 in HT-29 cells. A, X-Y scans of pan-PMCA
(panel i) and NHERF-2 (panel ii) revealing punctuate distribution and some
degree of co-localization (panel iii). B, Z-scan of HT-29 cells showed an apical-
lateral distribution of both PMCA (panel i) andNHERF-2 (panel ii) with a signif-
icant degree of colocalization (panel iii). Scale bar represents 10 m. These
images are representative of four separate experiments.
FIGURE 6. PMCA and NHERF-2 distribution in HT-29 cells exposed to
ACh. A, X-Y scans of pan-PMCA exposed to ACh for 60 s. This resulted in a
more pronounced punctuate distribution of PMCA (panel i) and NHERF-2
(panel ii) and a higher degree of colocalization (panel iii). B, Z-scan of the
same cells more clearly demonstrates the association of PMCA (panel i)
and NHERF-2 (panel ii) into larger punctuate structures (panel iii). Scale bar
represents 10 m. These images are representative of four separate
experiments.
PDZ-dependentMuscarinic Trafficking of PMCA
1826 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 284•NUMBER 3•JANUARY 16, 2009
 at UQ Library on September 5, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
PMCA is Ca2-independent, Ca2 is required for the nucle-
ation of the efflux complex at the membrane in response to
muscarinic stimulation.
DISCUSSION
PMCA-mediated Ca2 efflux plays a key role in regulating
basal [Ca2]i levels and the rates of recovery of [Ca2]i, thereby
shaping the Ca2 responses following activation of GPCRs.
One mechanism to regulate PMCA is through accessory/scaf-
fold proteins, and there has been recent interest in splice vari-
ants that involve C-terminal PDZ interactions. Here we
describe the molecular and physiological basis of the interac-
tion between endogenous PMCA1b and NHERF-2 in HT-29
cells.
Our finding that PMCA1b binds to NHERF-2 builds on the
previous study by DeMarco et al. (18) who showed in overex-
pression studies that PMCA2b but not PMCA4b bound to
NHERF-2. We also showed that, like PMCA2b, NHERF-1 did
not bind PMCA1b and also demonstrate that the in vitro inter-
action between PMCA and NHERF-2 does not require of Ca2
and that these two proteins have a constitutive association. The
previous study on NHERF-2 relied on exogenously expressed
PMCA2b and NHERF-2. The significance of the current study
is that we used HT-29 cells that endogenously express
NHERF-2 andPMCA1b to define the physiological relevance of
PMCA-NHERF-2 interactions.
NHERF-2 interacts with proteins involved in Ca2 signaling
via its PDZ2 module, such as the P2Y1 receptor (48). NHERF-2
also associates with metabotropic glutamine receptor 5
(mGluR5) to prolong intracellular Ca2 mobilization by
mGluR5 and thereby promoting mGluR5-mediated Ca2 tox-
icity (49). As a scaffold, NHERF-2
has been shown to stabilize or tether
membrane proteins in functionally
distinct complexes particularly in
polarized epithelial cells. This is
very apparent in the apical surfaces
of gastric epithelia, whereNHERF-2
forms the functional basis for the
coupling between lysophosphatidic
acid signaling and CFTR-mediated
chloride secretion (50). This tether-
ing also reduces the lateral mobility
in the cell membrane of these pro-
teins by anchoring the complex to
the underlying actin cytoskeleton
via accessory proteins such as ezrin,
which is highly expressed in gastric
epithelia (51). It has already been
shown that NHERF-2 is important
for the trafficking of membrane
transporters such as NHE3 (47) and
ion channels such as ClC-5 and
TRPV5 (39, 52). We have recently
also shown that NHERF-1 and
NHERF-2 differentially regulate
albumin uptake in renal proximal
tubule cells by mechanisms that
involve altering the cell-surface levels of ClC-5 in different
domains of the apical membrane (39).
These data shed new light as to howPMCAresponds to rapid
increases in [Ca2]i. The interaction between PMCA and
NHERF-2 does not require Ca2. The muscarinic-mediated
translocation of NHERF-2 to the membrane does not require
Ca2 but does depend on store-depletion. As the Ca2 levels
increase, PMCA moves to the membrane to form an efflux
complex with NHERF-2. This translocation of PMCA has an
absolute requirement for Ca2 and the presence of NHERF-2.
In contrast, treatment of cells with BAPTA-AM caused a sig-
nificant increase in both NHERF-2 and PMCA at the mem-
brane. The mechanisms underlying this effect are unclear. Ele-
vated cell surface levels of a protein can be achieved by
increased rates of insertion or reduced rates of removal of the
protein. In the case of NHERF-2, chelation of Ca2 simply
increased the levels of NHERF-2 at the membrane but did not
prevent the ACh-induced increase. Thus although there was a
shift in the baseline levels, there was no effect on the muscarin-
ic-evoked translocation. However, in the absence of Ca2,
PMCA levels increased to levels above that observed in control
cells treated with ACh. Furthermore, there was no change in
the cell surface levels of PMCA in response to ACh when the
Ca2 transient was abolished. This may relate to the internal-
ization pathway that was revealed in cells silenced for
NHERF-2. Under these conditions the ACh-induced increase
in membrane PMCA was abolished; however, the levels of
PMCAwere also reduced below baseline levels. One possibility
is that the membrane-associated PMCA is subject to constitu-
tive internalization by a process dependent on [Ca2]i. Chela-
tion of Ca2may abolish the internalization step resulting in an
FIGURE7.NHERF-2 silencingattenuates relativeCa2 recovery inHT-29 cells followingexposure toACh.
Cells were transfected with NHERF-2 silencing constructs as described and [Ca2]i assessed using a Fura-2-
based fluorometric assay. For all experiments, agonist injection was at 20 s. A, representative Fura-2 tracings
showing relative PMCA-mediated [Ca2]i recovery following an ACh-evoked Ca
2 transient (bath solutions;
zero Ca2, 5MCPA, extracellular BAPTA). B, relative PMCA-mediated Ca2 efflux was significantly reduced by
32 8% and 31 6% (n 4; **, p 0.01) for Shag 274 and Shag 361, respectively. C, no significant change in
peak [Ca2]i was observed. D, representative Fura-2 tracings showing relative [Ca
2]i recovery following an
ACh-evoked Ca2 transient in the absence of CPA (bath solution; zero Ca2, extracellular BAPTA). E, relative
Ca2effluxwas significantly reducedby503%and533% (n4; ***,p0.001) for Shag274andShag361,
respectively. F, no significant change in peak [Ca2]i was observed. All data are representative of 3–4 inde-
pendent assays where each group was measured from 6–8 wells and are expressed as mean S.E.
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accumulation of PMCA at the membrane and preventing the
normal trafficking. PMCA retrieval may be particularly sensi-
tive to [Ca2]i chelation because theC-terminal tail of PMCA is
less exposed in unstimulated pumps (autoinhibited state) (53).
An increase in [Ca2]i may be required to expose the C-termi-
nal tail, and in its absence, recycling of PMCAmight be turned
off and trafficking disrupted. Thus PMCA appears to exist in
pools that can be rapidly mobilized in response to increases in
Ca2 and that multiple and independent pathways exist for its
insertion and removal.
PMCA1b binds to PDZ2 yet the role of PDZ1 remains to be
determined in this context. One possibility is that NHERF-2
itself could dimerize (via the unoccupied PDZ1) (54) thereby
increasing the density of PMCA at the membrane. Another
possibility is that at rest, PMCA is concentrated in subapical
pools by homodimers of NHERF-2 but upon stimulation,
PMCA associates with NHERF-2 in a complex where PDZ1 is
occupied by another protein required for Ca2 efflux. Indeed,
shuffling of transporters between NHERF-1 and NHERF-2 has
been implicated for NHE3 in the renal proximal tubule (55).
NHERF-2 is also known to interact with proteins involved in
Gq-mediated signaling, including Gq itself, PKC, and
PLC. Thus, NHERF-2 may control PMCA activity during
muscarinic signaling by acting as a scaffold to link these key
signaling proteins in the vicinity of the muscarinic receptor.
NHERF-2 is known to up-regulate the PLC-3 activity coupled
to muscarinic receptor activation (56). In addition, the PLC
substrate phosphatidylinositol 4,5-bisphosphate (PIP2) is a
known activator of PMCA (6). Thus NHERF-2 may act to
ensure the close proximity of PMCA and PLC-3 and the shar-
ing of a common local pool of PIP2. In this context, it has been
recently demonstrated that the regulation of TRPC4 by PIP2
requires the presence of the PDZmotif on TRPC4. The authors
proposed a novel mechanism in which NHERF-cytoskeletal
interactions are necessary to stabilize the PIP2 binding site close
to the inner surface of the plasmamembrane (57). Importantly,
this mechanism may also underlie the PIP2 regulation of the
TRPC4-like muscarinic activated current in ileal myocytes
(58). The fact that NHERF-2 has been shown to associate with
TRPC4 in the rat vasa-recta provides further support for such a
role forNHERF-2 (59).Our data provide further support for the
agonist-induced assembly of supramolecular complexes that
contain the components required for spatio-temporal fine-tun-
ing of the Ca2 signal.
The overall shape of the Ca2 signal is critical, and up-regu-
lation of Ca2 efflux during the rising phase of the Ca2 tran-
sient would reduce the efficiency of Ca2 signaling (60, 61).
Thus the transient nature of PMCA trafficking in the case of
FIGURE 8. Depletion of Ca2 stores triggers PMCA and NHERF-2 traffick-
ing to the cell membrane. HT-29 cells were exposed to CPA (5 M) in the
absence of extracellular Ca2. A, representative Fura-2 tracing showing
changes in [Ca2]i following the addition of CPA (5 M) to the bathing solu-
tion at 20 s. B, representative Western blot showing changes in membrane-
associated PMCA during exposure to CPA. C, densitometry showing time-de-
pendent changes in membrane-associated PMCA during exposure to CPA.
Membrane levels of PMCA peaked to 61  12% (n  3; **, p  0.01) above
control levels at 120 s and returned to baseline levels by 300 s. D, represent-
ative Western blot showing changes in membrane-associated NHERF-2 dur-
ing exposure to CPA. E, densitometry showing changes inmembrane-associ-
ated NHERF-2 during exposure to CPA. Membrane levels of NHERF-2 peaked
by 180 11% (n 3; *, p 0.05; **, p 0.01; ***, p 0.001) and returned to
resting levels by 300 s. All data are expressed as mean S.E.
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muscarinic activation, suggests that PMCA1b is mobilized to
fine tune [Ca2]i only at the time when the peak phase of the
Ca2 signal is reached. The recruitment of PMCA to the mem-
brane is temporally constrained by NHERF-2 to correspond to
the Ca2 peak. This ensures that Ca2 efflux is only augmented
after the peak has been achieved and that Ca2 levels do not
reach excessive levels during the peak. This in turn influences
the duration and shape of the overall Ca2 responses. The
absence of sustained insertion of PMCA at the plasma mem-
brane also ensures that excess levels of PMCA at themembrane
during the plateau phase of the response do not prematurely
terminate the sustained Ca2 signal and subsequent down-
stream responses. Such downstream responses could include
the level of NFATc1-mediated transcription which is regulated
by the amount of net Ca2 entry across the plasma membrane
(62). NHERF-2 may also recruit modulator proteins such as
PKA, PKC PLC3, and tyrosine phosphatases (63) to the com-
plex with PMCA to further fine tune Ca2 levels within the
membrane microdomains. Indeed PMCA1 has been reported
to be the isoform most sensitive to activation by PKA (64, 65).
Such mechanisms could help to encode the diversity of cellular
responses mediated by increases in [Ca2]i.
In summary, this study presents a new insight into the com-
plex roles of PMCA in the fine-tuning of intracellular Ca2
transients during agonist-induced Ca2 signaling. We also
reveal the highly dynamic turnover of PMCA at the plasma
membrane and its association with specific protein complexes
responsible for Ca2 efflux in response to specific agonists.
Future studies will identify the other proteins that may be
involved in such Ca2 efflux complexes and the role of scaffold
proteins in conferring specificity of G-protein-mediated Ca2
signaling. Our demonstration of rapid agonist-induced translo-
cation of PMCA in a native cell type reveals a new mechanism
for regulatingCa2 efflux. The recent identification ofNHERFs
in the brain and other excitable cells (66), and the fact that the
brain specific PMCA 2b also binds NHERF-2 opens up the pos-
sibility that suchmechanisms of regulationmay bemorewidely
operative.
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